How to Treat Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Opening by briefly outlining the immunopathology of AAV, which includes GPA, MPA, and EGPA, Terrier explained that these small-vessel vasculitides are characterised by necrotising inflammation associated with ANCA, directed against either proteinase 3 (PR3) or myeloperoxidase (MPO).The disease is systemic and often involves multiple organs, such as the lungs and kidneys.'Where do new agents, like complement inhibitors, fit into the treatment landscape?'Congress Feature EULAR 2025
Authors
- Aleksandra Żurowska (ORCID: https://orcid.org/0000-0002-3354-5344)
Institutions
- International Center for Transitional Justice (US)
Publication Details
- Journal
- EMJ Rheumatology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.33590/emjrheumatol/jpsf7192
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00